financetom
Business
financetom
/
Business
/
CorMedix to Supply to DefenCath to Florida-based Dialysis Organization
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
CorMedix to Supply to DefenCath to Florida-based Dialysis Organization
Apr 8, 2024 11:20 AM

01:46 PM EDT, 04/08/2024 (MT Newswires) -- CorMedix ( CRMD ) said Monday it entered a five-year agreement to supply its DefenCath product to Florida-based dialysis organization ARC Dialysis.

DefenCath was approved in the US in November 2023 and CorMedix ( CRMD ) plans to commercialize the product in the inpatient setting starting April 15.

Price: 4.73, Change: +0.02, Percent Change: +0.42

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Santander Brasil's net profit rises 9.4% in Q3
Santander Brasil's net profit rises 9.4% in Q3
Oct 29, 2025
Oct 29 (Reuters) - Banco Santander Brasil ( BSBR ) on Wednesday reported a third-quarter net profit of 4.01 billion reais ($742.06 million), up 9.4% from a year earlier. ($1 = 5.4039 reais) ...
SiteOne Landscape beats Q3 sales estimates, plans to close additional branches in Q4
SiteOne Landscape beats Q3 sales estimates, plans to close additional branches in Q4
Oct 29, 2025
Overview * SiteOne Q3 net sales rise 4% to $1.258 bln, beating analyst expectations * Adjusted EBITDA for Q3 increases 11%, surpassing analyst estimates * Net income for Q3 grows 33% to $59.1 mln, driven by sales growth and margin improvement Outlook * SiteOne expects full-year 2025 Adjusted EBITDA of $405 mln to $415 mln * Company anticipates 1% to...
Form 8.3 - UNITE Group PLC/The
Form 8.3 - UNITE Group PLC/The
Oct 29, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Cybersecurity firm Radware's Q3 revenue beats on cloud security offerings strength
Cybersecurity firm Radware's Q3 revenue beats on cloud security offerings strength
Oct 29, 2025
Overview * Radware Q3 2025 revenue grows 8% yr/yr, beating analyst expectations * Non-GAAP diluted EPS rises to $0.28 vs. $0.23 in Q3 2024 * Cloud ARR accelerates 24% yr/yr, reinforcing cloud security offering Outlook * Radware ( RDWR ) did not provide specific financial guidance for the upcoming quarter or year Result Drivers * CLOUD ARR GROWTH - Cloud...
Copyright 2023-2026 - www.financetom.com All Rights Reserved